Latest Blog Posts Tagged "FDA-approved drugs"
February 28, 2019
With a new Parkinson's drug for "off" time on the market and another under FDA review, you may wonder if one of these as-needed treatments is right for you.
October 05, 2018
An MJFF survey evaluated patients' and clinicians' perspectives on and experiences with Rytary in the "real world," outside of clinical trials.
September 21, 2018
The designation applies to drugs that have shown an effect on a serious condition or symptom in early clinical data.
March 08, 2018
With a new drug on the market to treat PD symptoms, it's important to discuss why you might consider one drug over another.
March 22, 2017
The U.S. Food and Drug Administration (FDA) has approved a new drug called Xadago (safinamide) from Newron Pharmaceuticals for people with Parkinson's disease (PD) who are taking levodopa.
March 10, 2017
Generic medications are substitutes for brand name drugs. They're typically less expensive, widely available and commonly prescribed.
May 31, 2016
Nuplazid, a drug indicated for the treatment of Parkinson's disease psychosis, is now available for prescription.
May 18, 2016
The FDA recently published a report detailing the impact of Parkinson's disease (PD) on patients and their loved ones.
April 29, 2016
The Food and Drug Administration has approved Nuplazid to treat Parkinson's psychosis.
May 06, 2015
Dr. Rachel Dolhun tells Practical Neurology about recently approved levodopa formulations that may help avoid wearing off and dyskinesia.